|
Market Cap (4-Jun) $35,464,388 (1,259th) |
Close (30-Jun) $0.080 |
Volume (30-Jun) 244,049 |
Shortsold (15-Jan) 38,875 (0.01%) (540th) |
|
52w High $0.260 |
52w Low $0.054 |
P/E - |
EPS -0.02 |
NSB released this announcement to the ASX on 3 September 2021, 9:05. The announcement is marked as price sensitive, and is 2 page(s) in length and 114.12kb in size.
You can view all announcements from NSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, NSB was 0.013% short sold according to ASIC data. It was ranked the 584th most shorted stock on the ASX. It is now ranked as the 540th most shorted stock on the ASX with 0.012% of total shares short sold as of the latest reported data (15 January 2026).
| Other Recent Announcements from NSB | |
|---|---|
| Change of Director's Interest Notice - Rennie | 7 June 2023, 8:22 |
| Change of Director's Interest Notice - Uvarov | 25 May 2023, 15:30 |
| Change of Director's Interest Notice - Rennie | 25 May 2023, 15:07 |
| NSB Receives R&D Advance & Overseas Finding | 3 September 2021, 9:05 |
| Positive Results in Multiple Sclerosis Study | 31 August 2021, 8:05 |
| 2021 Annual Report and Appendix 4E | 27 August 2021, 13:33 |
| NSB appoints International Scientific Advisors | 24 August 2021, 9:22 |
You must be logged in to post a reply.
NeuroScientific Biopharmaceuticals 